East Farmingdale, NY- Drug maker Pfizer released information early Wednesday morning about the effectiveness of its COVID-19 vaccine, against the Omicron variant. Pfizer said preliminary studies showed that two doses alone “might not provide a sufficient immune response against the variant” but that studies showed that a booster shot, “helps neutralize the variant”.
The CDC approved booster shots of COVID-19 vaccines for everyone in the United States ages 18 and older.
Read the full release from Pfizer, here
Photo: FILE – Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe, Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Mass. Pfizer said Wednesday, Dec. 8, 2021, that a booster dose of its COVID-19 vaccine may protect against the new omicron variant even though the initial two doses appear significantly less effective. (AP Photo/Steven Senne, File)
